APTX (APTX) News
Follow APTX (APTX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Apotex Reports Second-Quarter Results, Raises Fiscal 2027 Guidance
Apotex reported second-quarter fiscal 2027 results and raised its full-year fiscal 2027 guidance.
EQUITY | Nov 12, 2026, 12:33 PM UTC
M
Apotex Health Raises Fiscal 2027 Revenue Growth Outlook to 9%–10%
Apotex Health raised its fiscal 2027 revenue growth outlook to 9%–10% after new drug launches and higher sales drove fiscal second-quarter earnings higher.
EQUITY | Nov 12, 2026, 11:38 AM UTC
M
Apotex Reports Second-Quarter Results and Raises FY2027 Guidance
Apotex reported adjusted EBITDA of $280 million with a 33% margin. It raised its FY2027 outlook to about 9–10% revenue growth and about a 31% adjusted EBITDA margin.
EQUITY | Nov 12, 2026, 10:59 AM UTC
L
Apotex Health Corp. (APTX) Prices $1.25B Senior Unsecured Notes
Apotex Health Corp. priced $1.25B in senior unsecured notes across 2029, 2031 and 2033 maturities at coupons of 4.390%, 4.769% and 5.133%, respectively. Proceeds are expected to refinance debt and for general purposes; c
NEWS | Sep 28, 2026, 08:40 PM UTC
L
APOTEX HEALTH CORP. ANNOUNCES $1,250 MILLION INAUGURAL SENIOR UNSECURED NOTES OFFERING
Not for distribution to U.S. news wire services or dissemination in the United States.TORONTO, Sept. 28, 2026 /CNW/ -- Apotex Health Corp. (TSX:APTX) ("Apotex" or the "Company") announced today that it has priced a priva
NEWS | Sep 28, 2026, 08:40 PM UTC